Associated Papers
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways.
Magistroni V et al.
Haematologica, 2019
Select a paper to view details
Magistroni V et al.
Haematologica, 2019